MedTrace Logo

Hypertension Prevention Trial (HPT) Feasibility Study

NCT00000501 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2013-11-26

No results posted yet for this study

Summary

To test the feasibility and the efficacy of nutritional interventions in the primary prevention of hypertension in individuals predisposed to the development of hypertension; specifically, to test the hypothesis that reduction of weight and/or decreased sodium intake in obese individuals, or decreased sodium intake with or without increased potassium intake (in men and women, regardless of weight) would prevent the elevation of blood pressure and the incidence of hypertension.

Conditions

Interventions

BEHAVIORAL

diet, sodium-restricted

BEHAVIORAL

diet, reducing

DRUG

potassium

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Nemat Borhani · University of California, Davis

  • Robert Jeffery · University of Minnesota

  • Herbert Langford · University of Mississippi Medical Center

  • Albert Oberman · University of Alabama at Birmingham

  • Ronald Prineas · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1981-09-30
Completion
1986-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000501 on ClinicalTrials.gov